
In this episode of TOP: The Oculofacial Podcast, Host Dr. Jordan Conger leads a Journal Club reviewing articles from the September/October 2026 issue of OPRS. Joining him are Dr. Jamie Keen, discussing long-term proptosis outcomes following teprotumumab treatment for thyroid eye disease; Dr. Shravani Mikkilineni, examining the relationship between eyelid xanthelasma and cardiovascular outcomes; and Dr. Christopher Dermarkarian, exploring industry payments among oculofacial plastic surgeons and the potential implications of physician-industry relationships. Together, the panel discusses the research, its limitations, and how these findings may influence clinical decision-making and patient care.
Mais episódios de "The Oculofacial Podcast"



Não percas um episódio de “The Oculofacial Podcast” e subscrevê-lo na aplicação GetPodcast.








